HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

cetuximab (Erbitux)

is an antibody that blocks receptors for epidermal growth factor
Also Known As:
Erbitux; C225; IMC C225; IMC-C225; MAb C225
Networked: 2724 relevant articles (449 outcomes, 824 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Ciardiello, Fortunato: 35 articles (11/2015 - 08/2002)
2. Tonini, Giuseppe: 25 articles (11/2015 - 04/2005)
3. Tejpar, Sabine: 25 articles (06/2015 - 08/2007)
4. Van Cutsem, Eric: 25 articles (06/2015 - 07/2004)
5. Siena, Salvatore: 24 articles (11/2015 - 07/2004)
6. Tabernero, Josep: 23 articles (12/2015 - 08/2005)
7. Lenz, Heinz-Josef: 23 articles (10/2015 - 09/2004)
8. Santini, Daniele: 23 articles (09/2014 - 04/2005)
9. Grandis, Jennifer R: 21 articles (12/2015 - 07/2007)
10. Bardelli, Alberto: 21 articles (07/2015 - 05/2005)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
2. Neoplasms (Cancer)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Squamous Cell Carcinoma (Epidermoid Carcinoma)
5. Head and Neck Neoplasms (Head and Neck Cancer)

Related Drugs and Biologics

1. irinotecan (Camptosar)
2. bevacizumab
3. Epidermal Growth Factor Receptor (EGF Receptor)
4. oxaliplatin (Eloxatin)
5. panitumumab (Vectibix)
6. Fluorouracil (Carac)
7. cetuximab (Erbitux)
8. Leucovorin (Folinic Acid)
9. Cisplatin (Platino)
10. Monoclonal Antibodies

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Radiotherapy
3. Heterologous Transplantation (Xenotransplantation)
4. Combination Drug Therapy (Combination Chemotherapy)
5. Salvage Therapy